| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/11/2008 | EP1930346A1 Antibody produced using ostrich and method for production thereof |
| 06/11/2008 | EP1930026A1 A method for generating birnavirus from synthetic RNA transcripts |
| 06/11/2008 | EP1930025A1 ANTIGEN-AND-DRUG VEHICLE WHICH ENABLES THE CHANGEOVER FROM THE SELECTIVE PRODUCTION OF IgA ANTIBODY TO THE PRODUCTION OF BOTH OF IgA AND IgG ANTIBODIES, AND TRANSNASAL/TRANSMUCOSAL VACCINE USING THE VEHICLE |
| 06/11/2008 | EP1930022A1 Treatment of bladder fibrosis with antibodies against alpha V beta 6 integrin |
| 06/11/2008 | EP1929303A2 Assay and kits therefor |
| 06/11/2008 | EP1929050A2 Compositions and methods using same for the detection of viruses |
| 06/11/2008 | EP1929047A2 Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity |
| 06/11/2008 | EP1929043A2 Genemap of the human genes associated with crohn's disease |
| 06/11/2008 | EP1929034A1 Cancerous disease modifying antibodies |
| 06/11/2008 | EP1929033A1 Cancerous disease modifying antibodies |
| 06/11/2008 | EP1929021A2 Adenoviral vector-based malaria vaccines |
| 06/11/2008 | EP1928916A2 Immunomodulatory compositions and uses therefor |
| 06/11/2008 | EP1928913A2 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 06/11/2008 | EP1928905A2 Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use |
| 06/11/2008 | EP1928898A1 Fish vaccine |
| 06/11/2008 | EP1928497A2 Combination therapies for inhibiting integrin-extracellular matrix interactions |
| 06/11/2008 | EP1928496A2 C/clp antagonists and methods of use thereof |
| 06/11/2008 | EP1928495A2 Antibody-mediated enhancement of immune response |
| 06/11/2008 | EP1928494A2 Combination therapy for immunostimulation |
| 06/11/2008 | EP1928493A2 Stabilization of clostridium botulinum neurotoxin complex |
| 06/11/2008 | EP1928492A2 Immunological uses of immunodulatory compounds for vaccine and anti-infections disease therapy |
| 06/11/2008 | EP1928419A1 Multivalent liposomal vaccine compositions comprising polysaccharide antigens and a protein adjuvant |
| 06/11/2008 | EP1928418A1 Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant |
| 06/11/2008 | EP1928235A2 Composition and method for use in cartilage affecting conditions |
| 06/11/2008 | EP1490103B1 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthama(obstructive lung disease) |
| 06/11/2008 | EP1420769B1 Lipid profile modulation with steroids and ppar alpha agonists |
| 06/11/2008 | EP1372621B1 Novel use of tyrosine kinase frk inhibitor |
| 06/11/2008 | EP1350262B1 Cpg-like nucleic acids and methods of use thereof |
| 06/11/2008 | EP1301637B1 Dna vaccines encoding hiv accessory proteins |
| 06/11/2008 | EP1165113B1 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 06/11/2008 | EP1086137B1 Composition and method for modulating dendritic cell-t cell interaction |
| 06/11/2008 | EP0959900B1 Diagnosis of ulcerative colitis, and clinical subtypes thereof, using histone h1 |
| 06/11/2008 | EP0954529B1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis |
| 06/11/2008 | CN101198699A Porcine circovirus and helicobacter combination vaccines and methods of use |
| 06/11/2008 | CN101198698A Process for production of polypeptide by regulation of assembly |
| 06/11/2008 | CN101198692A HIV vaccine |
| 06/11/2008 | CN101198623A Methods and compositions for modulating and detecting WISP activity |
| 06/11/2008 | CN101198620A Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma |
| 06/11/2008 | CN101198353A Immunomodulating compositions and uses therefor |
| 06/11/2008 | CN101198352A C. perfringens alpha toxoid vaccine |
| 06/11/2008 | CN101198351A Compositions and methods for treating conditions related to EPHRIN signaling with cupredoxins |
| 06/11/2008 | CN101198345A LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized |
| 06/11/2008 | CN101198344A LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized |
| 06/11/2008 | CN101198339A Highly attenuated pox virus strains, method for the production thereof and the use thereof as paramunity inducers or for producing vector vaccines |
| 06/11/2008 | CN101195823A Novel bacterium surface exhibiting system, method and application of the same |
| 06/11/2008 | CN101195659A High anticoagulating active antihuman tissue factor monoclone antibody, preparation method and application thereof |
| 06/11/2008 | CN101195025A Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (tb4) analogues, isoforms and other derivatives |
| 06/11/2008 | CN100393878C Vaccine |
| 06/11/2008 | CN100393870C Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| 06/11/2008 | CN100393866C Live antenuated parasite vaccine |
| 06/11/2008 | CN100393748C Human tumour necrosin antibody, its preparation and medicinal composition |
| 06/11/2008 | CN100393746C Tumour antigen protein and tumour antigen peptide |
| 06/11/2008 | CN100393745C Tumour antigen protein and tumour antigen peptide |
| 06/11/2008 | CN100393358C Preparation of horse family animal anti human, pultry grippe immune globulin and its medicinal preparation |
| 06/11/2008 | CN100393357C Young schistosomiasis cell style vaccine for preventing from schistosomiasis disease |
| 06/10/2008 | US7385045 Naturally-occurring variants of B7 proteins produced by alternative RNA splicing or alternative termination of full-length amino acid sequence; regulation of immune response in an animal; immunostimulants; anticarcinogenic agents, infections; antiallergens; antiinflammatory agents; veterinary medicine |
| 06/10/2008 | US7385044 Comprises nucleotide sequences coding fusion protein ligand which binds major histocompatibility complex and human leukocyte antigen for use in detection and prevention of infections, cancer andautoimmune disorders |
| 06/10/2008 | US7385039 Methods and compositions for regulating imidazoline receptors |
| 06/10/2008 | US7385035 Cytotoxic protein and utilization thereof |
| 06/10/2008 | US7385033 PRO12970 polypeptides |
| 06/10/2008 | US7385032 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 06/10/2008 | US7384918 Botulinum toxin for treating muscle contracture |
| 06/10/2008 | US7384913 Inducing oocyte activation by administering sperm perinuclear theca protein 34; interacts with tyrosine kinase; enhancing fertility; treating or diagnosing diminished fertility and abnormal spermiogenesis, providing contraception; identifying contraceptive and fertility-enhancing agents |
| 06/10/2008 | US7384909 Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents |
| 06/10/2008 | US7384785 Diagnostic test for West Nile virus |
| 06/10/2008 | US7384775 Comprises nucleotide sequences coding surface localized streptococcal polypeptides for design of vaccines for prevention of non-systemic diseases such as otitis media; genetic vaccines |
| 06/10/2008 | US7384774 entirely vector-based intracellular system; introducing into a 293T cell expression vectors capable of expressing genomic or antigenomic vRNA segments, and a nucleoprotein, and an RNA-dependent polymerase |
| 06/10/2008 | US7384768 Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus |
| 06/10/2008 | US7384756 Methods for treating muscle diseases and disorders |
| 06/10/2008 | US7384735 Retinoblastoma nucleic acids |
| 06/10/2008 | US7384645 Outer membrane vesicles from gram negative bacteria and use as a vaccine |
| 06/10/2008 | US7384644 Modified Vaccinia Ankara virus variant |
| 06/10/2008 | US7384643 genetically engineered to be incapable of expressing a native A41L protein; binds to chemokines in the CXC group. |
| 06/10/2008 | US7384642 Canine influenza vaccines |
| 06/10/2008 | US7384641 A nucleic acid encoding an antigen(HIV gp12o or gp160) against which an immune response is desired in a HIV patient and a second component containing a nucleic acid encoding a chemokine, and a carrier |
| 06/10/2008 | US7384640 Mutant cholera holotoxin as an adjuvant |
| 06/10/2008 | US7384639 Methods of treating or preventing an infectious disease using an immunogenic conjugate of a gram-negative bacterial autoinducer molecule |
| 06/10/2008 | US7384638 includes polypeptides that contain at least one antigenic portion of a Chlamydia antigen and DNA sequences encoding such polypeptides |
| 06/10/2008 | US7384637 Drug for AIDS treatment |
| 06/10/2008 | US7384636 Which induce an antibody specific to cell surface protein antigen from Streptococcus; use in vaccine production and preventing dental caries |
| 06/10/2008 | US7384635 Protein variants of naturally occurring allergens |
| 06/10/2008 | US7384634 Polypeptide, Connective Tissue Growth Factor (CTGF), polynucleotides encoding CTGF and polynucleotides regulating CTGF expression. The invention also provides agents that modulate CTGF and therapeutic methods for using the agents |
| 06/10/2008 | US7384633 Human type antihuman IgE receptor antibody and fragment |
| 06/10/2008 | US7384632 for prevention and/or treatment of cellular degeneration, including nerve cell damage associated with acute nervous cell system injury and chronic neurodegenerative diseases, including peripheral neuropathy |
| 06/10/2008 | US7384631 Contacting myeloid cells in a sample with a ligand directed against p75/AIRM1(75 kd adhesion inhibitory receptor molecule1) receptor, and determining binding of the ligand |
| 06/10/2008 | US7384627 Antitumor agents with the use of HSV |
| 06/10/2008 | CA2423481C Isolated peptides which bind to hla-c molecules and uses thereof |
| 06/10/2008 | CA2286330C Anti-vegf antibodies |
| 06/10/2008 | CA2284107C Activation of peptides |
| 06/10/2008 | CA2191750C Virosome-mediated intracellular delivery of therapeutic agents |
| 06/10/2008 | CA2179420C Soft agar penetration-defective mutants |
| 06/10/2008 | CA2153756C Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, dna sequences encoding it and their use |
| 06/10/2008 | CA2113562C Poultry mycoplasma antigens, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same |
| 06/05/2008 | WO2008067532A2 Antagonists of pge2 ep3 receptors |
| 06/05/2008 | WO2008067464A2 NEW Aβ CONFORMER SELECTIVE ANTI-Aβ GLOBULOMER MONOCLONAL ANTIBODIES |
| 06/05/2008 | WO2008067427A2 Insulin-like growth factor-1 receptor antagonists for modulation of weight and liposity |
| 06/05/2008 | WO2008067283A2 Ovr110 antibody compositions and methods of use |
| 06/05/2008 | WO2008067234A2 Use of anti-cytokine agents for treating carpal and tarsal tunnel syndrome |
| 06/05/2008 | WO2008067115A2 Selective immunodepletion of endogenous stem cell niche for engraftment |
| 06/05/2008 | WO2008067084A2 Methods for reducing phosphate absorption |